Adi Hoess Email and Phone Number
Adi Hoess work email
- Valid
Adi Hoess personal email
Adi Hoess phone numbers
With nearly 30 years of experience in the biotech industry, I offer an expert scientific background coupled with proven success in business development, commercial leadership, and corporate strategy. Under my leadership, Affimed has focused its excellent science and biology, deep financial commitment, and entrepreneurial innovation on developing, validating, and eventually introducing drugs that give patients their lives back. Biotech companies exist to build bridges from research and discovery to drug development and commercialization for the ultimate purpose of success in patients. I maximize the impact of those efforts through IPOs, mergers and acquisitions, and collaboration agreements, such as:• Taking forward the groundbreaking ViaNautis' polyNaut nanovesicles to revolutionize genetic medicines.• Listing Affimed as a Dutch company on the NASDAQ. I presented this innovative strategy to the company’s Board of Directors with investment banks ready to back this novel IPO solution.• Taking a drug in a rare disease where there was high medical need but at that time no commercial interest and pursued development, registration and commercialization of a drug called Firazyr which has become a viable business helping patients get back to their normal activities.• Playing a significant role with Shire for the M&A of Jerini AG• Establishing novel antibody-based technologies and building a sustainable business through signing of multiple collaboration deals for MorphoSys, which were instrumental in the company’s successful German IPO.People are inspired and motivated by my example to think and explore outside the box, resulting in innovations that exceed expectations and impact people’s lives. For example, launching Jerini’s novel orphan medication, Firazyr, into the market allowed patients suffering with hereditary angioedema, a rare immune system disorder, to control their disease and participate in their daily activities.From my initial involvement at MorphoSys where I started in R&D and evolved into a senior business development and commercial leader, to today as CEO of Affimed, my passion for positive patient outcomes and giving people the right to live full and rewarding lives has remained constant.
-
Chief Executive OfficerVianautis Oct 2024 - PresentCambridge, Gb
-
Ceo | Brought Affimed From Early Stage Pre-Clinical Engineering To Late-Stage Clinical DevelopmentAffimed Ag 2011 - Jan 2024Mannheim, Bw, DeOver the last 10+ years, I have driven science, development, expansion, and culture within Affimed. Evolving the company from an antibody engineering focus to the leader in development of novel treatments for cancer patients that actualize the untapped potential of innate immunity having the first Innate Cell Engager in the clinic with registration-directed studies underway.In an unprecedented move for any German company, I proposed to the Board of Directors an innovative solution to take the company public – list Affimed as a Dutch company on the NASDAQ. This was the first IPO for a German biotech company in 10 years and led to a public offering model that has been adopted and replicated nationwide.My leadership resulted not only in signed collaborations with Genentech and Roivant, but also agreements with Johnson & Johnson, Merck, Roche, MDACC, Artiva and others, plus international expansion with an office opened in New York City.In 2011, Affimed employed approximately 30 employees. I built a high-performing team of talented entrepreneurial biotech and seasoned pharmaceutical leaders. Validating and leveraging Affimed’s high-quality work attracted 80+ qualified candidates, and grew the business to more than 100 valued employees. Culture is very important to today’s workforce, especially in a growing biotech. I addressed this opportunity by engaging one quarter of employees across all organizational levels to develop the company culture. Every employee was represented in the definition of vision and mission. We shaped a dichotomy that effectively integrates behavioral and biotech cultures with a focus on innovation and character-based values. The greatest success regarding this endeavor is that we are living that culture. -
Chief Executive Officer (Ceo) | Secured €30M Investment To Form & Launch Spin-Off From Jerini AgJenowis Ag 2009 - 2010I formed Jenowis AG following Shire’s acquisition of Jerini AG and as part of the asset buyback agreement. The new company never became operational.
-
Chief Commercial Officer | Introduced & Commercialized Firazyr | Key Player In Shire’S M&A ProcessJerini Ag 2002 - 2009DeMy primary goal and accomplishment with Jerini involved launching Firazyr into the EU market. A highly valuable medication used to treat the symptoms of a rare immune system disorder, hereditary angioedema, I believed in the safety and efficacy of Firazyr to give patients their right to live a normal life. It helped to remove the stigma of the disease from hereditary angioedema and allowed these patients to join society in any daily activities. On the transactional side of the business, I worked directly with Shire leaders during the M&A process of acquiring Jerini AG, which included an asset buyback agreement and led to a spin-off into Jenowis. I was instrumental in reacquiring the US rights for Firazyr from Abbott, prior to the acquisition by Shire. As a leadership team, we took Jerini public on the Frankfurt exchange. -
General Manager And Vice President Of Molecular Medicine DivisionCarl-Zeiss 2000 - 2002
-
Vice President, Licensing And Business Development | Director, Business Development | Biotech IpoMorphosys 1997 - 2000Planegg, Bayern, DeI transitioned to a business development role and was named VP in 1999. I signed multiple in- and out- licensing deals, which was instrumental in the company’s IPO. -
Scientist | Management Of Discovery UnitMorphosys 1993 - 1997Planegg, Bayern, De
Adi Hoess Education Details
-
Harvard Medical SchoolPost Doctorate -
Technical University Of MunichDoctorate Of Medicine
-
University Of MunichBiochemistry
Frequently Asked Questions about Adi Hoess
What company does Adi Hoess work for?
Adi Hoess works for Vianautis
What is Adi Hoess's role at the current company?
Adi Hoess's current role is Leading Science & Business to Deliver Drugs that Impact Patients’ Lives.
What is Adi Hoess's email address?
Adi Hoess's email address is a.****@****med.com
What is Adi Hoess's direct phone number?
Adi Hoess's direct phone number is +1 *****
What schools did Adi Hoess attend?
Adi Hoess attended Harvard Medical School, Technical University Of Munich, University Of Munich.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial